Dilon Technologies showcased its work-in-progress, GammaLoc, at RSNA’s annual meeting in Chicago last month. The gamma-guided biopsy system is likely to be available sometime in 2008 or 2009. The dual-mode stereotactic apparatus localizes occult lesions with the use of a slant-hole collimator.
The localization kit attaches to the Dilon 6800 Gamma Camera and allows the acquisition of a stereo pair of scintimammographic images without repositioning the camera between acquisitions. The Newport News, Va.-based company said its breast-specific gamma imaging (localized imaging) of the Gamma Camera is a nuclear breast imaging technique that allows physicians to see the breast more clearly by accessing a map of cellar metabolism.